332 related articles for article (PubMed ID: 24306928)
1. A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.
Wu Y; Tang M; Wu Y; Weng X; Yang L; Xu W; Yi W; Gao J; Bode AM; Dong Z; Cao Y
Cell Oncol (Dordr); 2014 Feb; 37(1):53-67. PubMed ID: 24306928
[TBL] [Abstract][Full Text] [Related]
2. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
[TBL] [Abstract][Full Text] [Related]
3. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
Mitra M; Kandalam M; Sundaram CS; Verma RS; Maheswari UK; Swaminathan S; Krishnakumar S
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5441-8. PubMed ID: 21546534
[TBL] [Abstract][Full Text] [Related]
4. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
[TBL] [Abstract][Full Text] [Related]
5. Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel.
Zhu HW; Jiang D; Xie ZY; Zhou MH; Sun DY; Zhao YG
Genet Mol Res; 2015 Dec; 14(4):18695-702. PubMed ID: 26782519
[TBL] [Abstract][Full Text] [Related]
6. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
Wang S; Akhtar J; Wang Z
Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.
Xie L; Song X; Guo W; Wang X; Wei L; Li Y; Lv L; Wang W; Chen TC; Song X
Oncotarget; 2016 Jan; 7(2):1651-62. PubMed ID: 26625208
[TBL] [Abstract][Full Text] [Related]
8. Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel.
Feng W; Xiaoyan X; Xuan Y; Xiangke L; Zichang Y; Ran Z; Liuxing W; Qingxia F
Cancer Gene Ther; 2015 Apr; 22(3):115-21. PubMed ID: 25572118
[TBL] [Abstract][Full Text] [Related]
9. Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma.
Wang C; Cheng Y; Liu H; Xu Y; Peng H; Lang J; Liao J; Liu H; Liu H; Fan J
Cell Physiol Biochem; 2016; 39(5):1795-1803. PubMed ID: 27744436
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells.
Long M; Yin G; Liu L; Lin F; Wang X; Ren J; Wei J; Dong K; Zhang H
Cancer Gene Ther; 2012 Apr; 19(4):271-81. PubMed ID: 22281755
[TBL] [Abstract][Full Text] [Related]
11. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
[TBL] [Abstract][Full Text] [Related]
12. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
[TBL] [Abstract][Full Text] [Related]
13. Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway.
Wang X; Ren JH; Lin F; Wei JX; Long M; Yan L; Zhang HZ
Cancer Biol Ther; 2010 Sep; 10(6):632-43. PubMed ID: 20657188
[TBL] [Abstract][Full Text] [Related]
14. Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression.
Zhu H
Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110249. PubMed ID: 32736275
[TBL] [Abstract][Full Text] [Related]
15. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
[TBL] [Abstract][Full Text] [Related]
16. A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.
Chen R; Zhang D; Mao Y; Zhu J; Ming H; Wen J; Ma J; Cao Q; Lin H; Tang Q; Liang J; Feng Z
Mol Cancer Ther; 2012 Mar; 11(3):594-603. PubMed ID: 22169768
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells.
Du C; Wen B; Li D; Lin Y; Zheng Y; Peng X; Hong C; Chen J; Lin W; Hong X; Xie L; Wu M
Tumori; 2006; 92(2):140-8. PubMed ID: 16724694
[TBL] [Abstract][Full Text] [Related]
18. RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo.
Long D; Yu T; Chen X; Liao Y; Lin X
Cell Biol Toxicol; 2018 Feb; 34(1):7-21. PubMed ID: 28589243
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.
Jeong JY; Kim KS; Moon JS; Song JA; Choi SH; Kim KI; Kim TH; An HJ
Apoptosis; 2013 Apr; 18(4):509-20. PubMed ID: 23371322
[TBL] [Abstract][Full Text] [Related]
20. Op18/stathmin is involved in the resistance of taxol among different epithelial carcinoma cell lines.
Lin X; Liao Y; Xie J; Liu S; Su L; Zou H
Cancer Biother Radiopharm; 2014 Nov; 29(9):376-86. PubMed ID: 25379611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
